Stocks
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -3.94 | 3.37 | 2.58 | 1.82 | 1.64 | -0.03 | |||
| Changes by years, y/y, % | -374% | -186% | -24% | -30% | -10% | +2.7% | |||
Arrowhead Pharmaceuticals. Debt/EBITDA
Arrowhead Pharmaceuticals. Debt/EBITDA, changes, %
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 2.23 | 1.59 | 0.38 | 0.28 | -0.03 | -0.03 | ||
| Changes by years, y/y, % | -2% | -8% | -86% | -90% | -102% | |||
| Changes by quarters, q/q, % | -21% | -29% | -76% | -26% | -112% | |||
